Matinas BioPharma Holdings, Inc. (MTNB)
0.638
+0.03
(+5.75%)
USD |
NYAM |
Mar 11, 16:00
Matinas BioPharma Holdings EPS Diluted (Quarterly) : -0.3955 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.15M |
| Total Expenses (Quarterly) | 2.15M |
| Enterprise Value | 0.9362M |
| Earnings Yield | -534.5% |
| Normalized Earnings Yield | -370.72 |